Christopher J. Sayed

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

Amit Garg, Erica Neuren, Denny Cha et al. · Journal of the American Academy of Dermatology · 2019 · 268 citations · Full text

Health Policy, Global Survey, Patient Safety +7

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

Sophie Glatt, Gregor B. E. Jemec, Seth Forman et al. · JAMA Dermatology · 2021 · 158 citations · Full text

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Christopher J. Sayed et al. · The Lancet · 2024 · 128 citations · Full text

Moderate-to-severe Hidradenitis Suppurativa, Be Heard Ii, Be Heard +3

Genetic Variants Associated With Hidradenitis Suppurativa

Quan Sun, K. Alaine Broadaway, Sharon N. Edmiston et al. · JAMA Dermatology · 2023 · 57 citations · Full text

Development and validation of <scp>IHS4</scp>‐55, an <scp>IHS4</scp> dichotomous outcome to assess treatment effect for hidradenitis suppurativa

Thrasyvoulos Tzellos, Kelsey R. van Straalen, Αthanassios Kyrgidis et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 54 citations · Full text